Alpha 2.0
Login Register
» Authors » Alessandra Salotti

Alessandra Salotti

Explore the profile of Alessandra Salotti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 38
Followers 0
Related Specialties
Endocrinology
Microbiology
Ophthalmology
Top 10 Co-Authors
Mario Falciano
Vincenzo Vullo
Angela Ermocida
Ivano Mezzaroma
Daniele Diacinti
Cristiana Cipriani
Claudio M Mastroianni
Ilaria Sauzullo
Jessica Pepe
Fabio Mengoni
Published In
Clin Endocrinol (Oxf)
Ocul Immunol Inflamm
New Microbiol
Endocrine
J Immunol Methods
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study
Pavone P, Giustini N, Fimiani C, Paoletti F, Falciano M, Salotti A, et al.
Curr HIV Res . 2017 Oct; 15(5):355-360. PMID: 28969567
Background: Raltegravir (RAL) is considered one of the better-tolerated antiretroviral medications, due to limited side effects and minimal drug-drug interactions. Matherials and Methods: We retrospectively evaluated 96 HIV+, over 60...
2.
An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1-infected women independently of protease inhibitors therapy: a pilot study
Pepe J, Mezzaroma I, Fantauzzi A, Falciano M, Salotti A, Di Traglia M, et al.
Endocrine . 2015 Aug; 53(1):299-304. PMID: 26254790
The best repletion and maintenance dosing regimens with cholecalciferol in vitamin D-deficient HIV-1 patients remain unknown. Protease inhibitors (PIs) have been shown to inhibit vitamin D 1α- and 25α-hydroxylation in...
3.
Levofloxacin and Tobramycin for Severe Bacterial Keratouveitis
Accorinti M, Colao L, Gilardi M, Cecere M, Salotti A, Pesci F
Ocul Immunol Inflamm . 2015 Jul; 24(5):482-8. PMID: 26172919
Purpose: To report on clinical features and outcome of severe bacterial keratouveitis. Methods: Twenty patients with severe bacterial keratouveitis treated with topical tobramycin and levofloxacin and oral levofloxacin were included....
4.
Long-term IFN-γ and IL-2 response for detection of latent tuberculosis infection in healthcare workers with discordant immunologic results
Sauzullo I, Mastroianni C, Mengoni F, Ermocida A, Mascia C, Salotti A, et al.
J Immunol Methods . 2014 Aug; 414:51-7. PMID: 25111618
Discordant results between the interferon-gamma release assays (IGRAs) and tuberculin skin test (TST) are common in latent tuberculosis infection (LTBI). We evaluated whether the measurement of IFN-γ and interleukin (IL)-2T-cell...
5.
Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response
Sauzullo I, Mengoni F, Ermocida A, Massetti A, DAgostino C, Russo G, et al.
New Microbiol . 2014 May; 37(2):153-61. PMID: 24858642
The objective of the study was to: 1) investigate the performance of QuantiFERON-TB Gold In-Tube (QFT-GIT) in HIV-infected patients with active tuberculosis (TB); 2) evaluate the sequential changes in QFT-GIT...
6.
The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture
Pepe J, Isidori A, Falciano M, Iaiani G, Salotti A, Diacinti D, et al.
Clin Endocrinol (Oxf) . 2012 May; 77(5):672-8. PMID: 22630782
Objective: Osteoporosis and hypogonadism are common in men with HIV infection. Ageing Male Symptoms (AMS) scale measures symptoms related to hypogonadism. FRAX provides 10-year probability of major fractures. We investigated...